A study of avalanche survival data shows that survival rates have increased and rescues are faster, but time is still ...

The American Cancer Society released its biennial update on breast cancer trends Tuesday, marking the start of Breast Cancer ...

Patients with soft tissue sarcomas showed improved functional results, quality of life and fewer side effects when treated ...

The trout, born on Halloween in 2023, were raised at the Roaring Fork Conservancy for almost a year before they were released ...

A grieving sister is suing a hospital in New Jersey amid revelations that they kept her brain-dead brother alive for four ...

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher ...

Lu-Dotatate may be considered “a rational therapeutic choice” for patients with refractory meningioma, according to Kenneth Merrell, MD.

Queensland Premier Steven Miles has unveiled what he's calling the first stage of his plan for cheaper energy. It will see ...

An Osaka Metropolitan University research team analyzed how diabetes mellitus and obesity factor into recurrence and survival ...

The incidence of colon cancer is rising globally, particularly among younger individuals who exhibit different symptoms and ...

Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show ...

A radionuclide agent, Lu-177 dotatate was approved by the FDA in 2018 for gastroenteropancreatic neuroendocrine tumors ...